$ARDX 4 SEC Filings

Filed On	Filing
25 Aug 2026	Form 4: Hohenleitner Susan, Chief Financial Officer Sold 1,558 shares ($6.01K)
25 Aug 2026	Form 4: Reilly Joseph James, See Remarks Sold 3,982 shares ($15.4K)
25 Aug 2026	Form 4: Bishop John E, See Remarks Sold 19,750 shares ($76.2K)
25 Aug 2026	Form 4: Brady James Parker, Chief Human Resources Officer Sold 15,136 shares ($58.4K)
25 Aug 2026	Form 4: Foster Eric Duane, Chief Commercial Officer Sold 8,562 shares ($33K)
25 Aug 2026	Form 4: Kelliher Mike, Chief Business Officer Sold 7,758 shares ($29.9K)
25 Aug 2026	Form 4: Williams Laura A, Chief Patient Officer Sold 10,739 shares ($41.4K)
25 Aug 2026	Form 4: Raab Michael, Director Sold 58,574 shares ($226K)
17 Jul 2026	Form 4: Raab Michael, Director Received 20,834 shares by exercise or conversion ($20.6K) · Sold 41,668 shares ($211K)
22 Jun 2026	Form 4: Williams Laura A, Chief Patient Officer Received 31,000 shares by exercise or conversion ($30.7K) · Sold 81,898 shares ($490K)
18 Jun 2026	Form 4: Parsey Merdad, Director Received 26,455 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Rodgers Richard J, Director Received 26,455 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Mott David M, Director Received 46,737 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Cadoret-Manier Onaiza, Director Received 26,455 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Bhanji Muna, Director Received 26,455 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Bertrand William C Jr, Director Received 38,800 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Bazemore Robert B, Director Received 26,455 shares as a grant or award · Granted 39,715 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Raab Michael, Director Received 20,833 shares by exercise or conversion ($20.6K) · Sold 41,666 shares ($236K)
22 May 2026	Form 4: Reilly Joseph James, See Remarks Sold 3,719 shares ($23.3K)
22 May 2026	Form 4: Hohenleitner Susan, Chief Financial Officer Sold 1,455 shares ($9.12K)

Comments